Enliven Therapeutics Inc.

19.64
-1.19 (-5.71%)
At close: Mar 03, 2025, 3:59 PM
19.62
-0.10%
After-hours: Mar 03, 2025, 04:13 PM EST

Enliven Therapeutics Inc. AI Forecast

Stock Price Forecast

Using our AI model trained on historical data, we generated a 12‑month forecast for Enliven Therapeutics Inc. (ELVN) stock. The model estimates a median target price of 34.68—ranging from a low of 11.86 to a high of 58.4—which suggests an increase of 76.58% compared to the current price of 19.64.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $11.86 $33.77 $34.68 $58.4
Change -39.61% 71.95% 76.58% 197.35%